Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
405 Leser
Artikel bewerten:
(1)

American IRA, LLC: American IRA Discusses What Are the Potential Pitfalls When Funding a Self-Directed IRA

Finanznachrichten News

ASHEVILLE, NC / ACCESSWIRE / April 9, 2021 / What are the potential pitfalls that investors should avoid when funding a Self-Directed IRA? According to a recent post at American IRA, a Self-Directed IRA administration firm based in Asheville, NC, pitfalls include not putting enough research into understanding the various funding methods, or not taking action quickly enough to make sure that a rollover is complete, which can potentially create a taxable event with the IRS.

In the post, American IRA highlighted the different funding methods available for investors. For example, some investors simply choose to open an account and begin funding via direct contribution. This funding method is the most straight-forward and comes with straight-forward rules as it applies to contribution limits. For example, if a Self-Directed IRA investor opens a Self-Directed Roth IRA, they would be subject to the contribution limits of their age. But this arrangement also makes it easy to open an account and begin investing.

Other investors, the post notes, may have different investing needs. For example, it is possible to rollover an existing account into an IRA, which can potentially create a taxable event if investors aren't careful. The post details the kind of research that an investor should perform before taking on a rollover. It also details other methods of funding Self-Directed IRA accounts, such as transfers.

"It's important for investors to know their options when funding," says Jim Hitt, CEO of American IRA. "This post outlines the pitfalls that investors should avoid if they're going to do it effectively. Because when it comes to funding an IRA, there are certainly wrong ways to do it. And knowing these wrong ways can help investors avoid pitfalls that create a taxable event and incur penalties."

The post expands upon these concepts in greater detail and explores the various funding methods available to certain investors-while noting that these funding methods can differ, depending on each investor's situation.

For more information about these pitfalls, be sure to visit the website at www.AmericanIRA.com. Interested parties may also contact the Self-Directed IRA administration firm by dialing 866-7500-IRA.

About:
"American IRA, LLC was established in 2004 by Jim Hitt, CEO in Asheville, NC.

The mission of American IRA is to provide the highest level of customer service in the self-directed retirement industry. Jim Hitt and his team have grown the company to over $500 million in assets under administration by educating the public that their Self-Directed IRA account can invest in a variety of assets such as real estate, private lending, limited liability companies, precious metals and much more.

As a Self-Directed IRA administrator, they are a neutral third party. They do not make any recommendations to any person or entity associated with investments of any type (including financial representatives, investment promoters or companies, or employees, agents or representatives associated with these firms). They are not responsible for and are not bound by any statements, representations, warranties, or agreements made by any such person or entity and do not provide any recommendation on the quality profitability or reputability of any investment, individual or company. The term "they" refers to American IRA, located in Asheville and Charlotte, NC."

SOURCE: American IRA, LLC



View source version on accesswire.com:
https://www.accesswire.com/636449/American-IRA-Discusses-What-Are-the-Potential-Pitfalls-When-Funding-a-Self-Directed-IRA

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.